dapi has been researched along with tacrolimus in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, RC; Elyaman, W; Hugon, J; Lin, KF; So, KF; Suen, KC | 1 |
Kaminska, B; Szydlowska, K; Zawadzka, M | 1 |
2 other study(ies) available for dapi and tacrolimus
Article | Year |
---|---|
Reduction of calcium release from the endoplasmic reticulum could only provide partial neuroprotection against beta-amyloid peptide toxicity.
Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; Blotting, Western; Boron Compounds; Calcium; Carrier Proteins; Caspase 3; Caspases; Cell Death; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Enzyme Inhibitors; Heat-Shock Proteins; Immunosuppressive Agents; Indoles; Intracellular Space; L-Lactate Dehydrogenase; Macrocyclic Compounds; Molecular Chaperones; Neurons; Oxazoles; Peptide Fragments; Rats; Rats, Sprague-Dawley; Tacrolimus; Time Factors | 2003 |
Neuroprotectant FK506 inhibits glutamate-induced apoptosis of astrocytes in vitro and in vivo.
Topics: Animals; Apoptosis; Astrocytes; Blotting, Western; Caspases; Cell Size; Cell Survival; Cells, Cultured; Cerebral Cortex; DNA Fragmentation; Enzyme Activation; Excitatory Amino Acid Antagonists; Fluorescent Dyes; Glial Fibrillary Acidic Protein; Glutamic Acid; In Situ Nick-End Labeling; Indoles; Infarction, Middle Cerebral Artery; Male; Membrane Potentials; Mitochondria; Neuroprotective Agents; Rats; Reperfusion Injury; Tacrolimus; Tetrazolium Salts; Thiazoles | 2006 |